{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:18:12Z","timestamp":1764937092328},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12985-019-1193-x","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T14:27:20Z","timestamp":1562250440000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lamivudine therapy for chronic hepatitis B in children: a meta-analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Aoran","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"S Aparna","year":"2015","unstructured":"Aparna S, Johannes H, Mikolajczyk RT, G\u00e9rard K, Ott JRJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546\u201355.","journal-title":"Lancet"},{"key":"1193_CR2","first-page":"427","volume":"13","author":"H Komatsu","year":"2015","unstructured":"Komatsu H, Inui A. Hepatitis B virus infection in children. Expert Rev Anti-Infect Ther. 2015;13:427\u201350.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"1193_CR3","first-page":"304","volume":"360","author":"M Marignani","year":"2009","unstructured":"Marignani M, Cox MC, Delle FG. Hepatitis B virus infection. New Engl J Med. 2009;360:304.","journal-title":"New Engl J Med"},{"key":"1193_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","volume":"48","author":"G Fattovich","year":"2008","unstructured":"Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335\u201352.","journal-title":"J Hepatol"},{"key":"1193_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jhep.2010.12.030","volume":"55","author":"SJ Hadziyannis","year":"2011","unstructured":"Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol. 2011;55:183\u201391.","journal-title":"J Hepatol"},{"key":"1193_CR6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"EASL","year":"2017","unstructured":"EASL. Clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370\u201398.","journal-title":"J Hepatol"},{"key":"1193_CR7","first-page":"8","volume":"42","author":"JN Williams","year":"1990","unstructured":"Williams JN. A window on the future: can computerization help your practice? Ky Dent J. 1990;42:8.","journal-title":"Ky Dent J"},{"key":"1193_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.28278","volume":"63","author":"MM Jonas","year":"2016","unstructured":"Jonas MM, Lok AS, Mcmahon BJ, Jr BR, Wong JB, Ahmed AT, Farah W, Mouchli MA, Singh S, Prokop LJ. Antiviral therapy in management of chronic hepatitis B viral infection in children: a systematic review and meta-analysis. Hepatology. 2016;63:307\u201318.","journal-title":"Hepatology"},{"key":"1193_CR9","unstructured":"Seagroatt V, Stratton I. Bias in meta-analysis detected by a simple, graphical test. Test had 10% false positive rate. BMJ. 1997;315:629."},{"key":"1193_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.hepres.2005.02.003","volume":"31","author":"M Figlerowicz","year":"2005","unstructured":"Figlerowicz M, Kowala-Piaskowska A, Filipowicz M, Bujnowska A, Mozer-Lisewska I, Sluzewski W. Efficacy of lamivudine in the treatment of children with chronic hepatitis B. Hepatol Res. 2005;31:217\u201322.","journal-title":"Hepatol Res"},{"key":"1193_CR11","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa012452","volume":"346","author":"MM Jonas","year":"2002","unstructured":"Jonas MM, Mizerski J, Badia IB, Areias JA, Schwarz KB, Little NR, Greensmith MJ, Gardner SD, Bell MS, Sokal EM. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med. 2002;346:1706\u201313.","journal-title":"N Engl J Med"},{"key":"1193_CR12","first-page":"9","volume":"09","author":"X Cheng","year":"2004","unstructured":"Cheng X, He q, Song W, Dong-Hong l, Dan S. A clinic study of lamivudine on the treatment of children with chronic hepatitis B. Chin Prim Med Pharm. 2004;09:9\u201310 [in Chinese.","journal-title":"Chin Prim Med Pharm"},{"key":"1193_CR13","first-page":"121","volume":"03","author":"Z Hong-min","year":"2011","unstructured":"Hong-min Z, Zhi-min N, Jing H, hui-fang L. Effect of Lamivudine Combined with Matrine on Treating Children with Chronic Hepatitis B. Res Integr Tradit Chin West Med. 2011;03:121\u20133 [in Chinese.","journal-title":"Res Integr Tradit Chin West Med"},{"key":"1193_CR14","first-page":"59","volume":"01","author":"L Ru-ping","year":"2006","unstructured":"Ru-ping L, Jing L, Jun-ming L, Xin-fang C. A study of lamivudine and HBV Vaccinum combined treatment of children with chronic hepatitis. J Clin Res. 2006;01:59\u201361 [in Chinese.","journal-title":"J Clin Res"},{"key":"1193_CR15","first-page":"344","volume":"02","author":"W Jin-feng","year":"2014","unstructured":"Jin-feng W, Dao-zhen Z. Clinical Observation of Lamivudine in Treating 40 Chronic Hepatitis B Patients. Mod Diagn Treat. 2014;02:344\u2013468 [in Chinese.","journal-title":"Mod Diagn Treat"},{"key":"1193_CR16","first-page":"2317","volume":"22","author":"H Shi-Juan","year":"2007","unstructured":"Shi-Juan H. Effect of Lamivudine on the Treatment of Children with Chronic Hepatitis B. Chongqing Medicine. 2007;22:2317\u20138 [in Chinese.","journal-title":"Chongqing Medicine"},{"key":"1193_CR17","first-page":"60","volume":"10","author":"F Yan-mei","year":"2011","unstructured":"Yan-mei F. Therapeutic effect of lamivudine on chronic hepatitis B in HBeAg positive children. J Clin Ration Drug Use. 2011;10:60\u20131 [in Chinese.","journal-title":"J Clin Ration Drug Use"},{"key":"1193_CR18","first-page":"16","volume":"01","author":"W Meng","year":"2012","unstructured":"Meng W, Xiong T, jin Z. Curative Effect of Lamivudine Tablets in Children with Chronic Hepatitis B. Pract Clin Med. 2012;01:16\u20138 [in Chinese.","journal-title":"Pract Clin Med"},{"key":"1193_CR19","first-page":"1366","volume":"10","author":"L Yu-qiong","year":"2006","unstructured":"Yu-qiong L, Wei H, Chang-jia W. Clinical observation of lamivudine in treating chronic hepatitis B in children. Chinese Maternal and Child Health Care. 2006;10:1366\u20137 [in Chinese.","journal-title":"Chinese Maternal and Child Health Care"},{"key":"1193_CR20","first-page":"1921","volume-title":"Clinical observation of lamivudine in the treatment of chronic hepatitis B in children. Modern diagnosis and treatment","author":"W Shui-ming","year":"2013","unstructured":"Shui-ming W, Cha-rong C, Zun-jia F. Clinical observation of lamivudine in the treatment of chronic hepatitis B in children. Modern diagnosis and treatment, vol. 09; 2013. p. 1921\u20133. in Chinese"},{"key":"1193_CR21","unstructured":"Qun G, Li Q, jin-bo W, Lei W, Bai-quan XU. Clinical observation of lamivudine in treating 42 cases of chronic hepatitis B in adolescents, vol. 12: Shan Dong Medicine; 2002. p. 44. [in Chinese"},{"key":"1193_CR22","unstructured":"Hong-mei Y. Research on Lamivudine in Treating Chronic Hepatitis B in Children [Master]: Nan Chang Univercity; 2010. [in Chinese]"},{"key":"1193_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.7326\/0003-4819-142-4-200502150-00006","volume":"142","author":"HL Chan","year":"2005","unstructured":"Chan HL. A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon- \u03b1 2b and lamivudine with lamivudine a lone. Ann Intern Med. 2005;142:240\u201350.","journal-title":"Ann Intern Med"},{"key":"1193_CR24","first-page":"404","volume":"44","author":"ES Mukadder Ay","year":"2010","unstructured":"Mukadder Ay ES, Sema A, Fatih U, Ay In Z, G\u00fcl Y, Ra It Vural Y. Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children. Pediatr Int. 2010;44:404\u20138.","journal-title":"Pediatr Int"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1193-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1193-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1193-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T23:16:36Z","timestamp":1593731796000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1193-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1193-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"2 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}